Encision Inc (ECIA)
OTHER OTC:ECIA
ECIA Stock Chart & Stats
$0.14
$0.03(7.14%)
At close: 4:00 PM EST
$0.14
$0.03(7.14%)
Day’s Range― - ―
52-Week Range$0.09 - $0.48
Previous CloseN/A
Volume5.10K
Average Volume (3M)16.18K
Market Cap
$2.19M
Enterprise Value$3.08M
Total Cash (Recent Filing)$71.73K
Total Debt (Recent Filing)$1.53M
Price to Earnings (P/E)―
Beta0.33
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,879,644
10 Day Avg. Volume10,380
30 Day Avg. Volume16,177
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)3.45
Price to Sales (P/S)0.87
P/FCF Ratio-42.25
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit0.93
Enterprise Value/Ebitda-12.82
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginsSustained ~53% gross margin indicates strong unit economics and pricing power in its medical-instruments niche. Over the next 2–6 months this margin buffer helps absorb SG&A volatility, making profitability achievable if operating costs are controlled or reduced.
Periodic Positive Cash GenerationHistory of intermittent positive operating and free cash flow shows the business can generate internal funding during better operating periods. This demonstrates underlying cash-generative potential that management can target to stabilize liquidity over the medium term.
Planned Deregistration To Cut Compliance CostsVoluntary SEC deregistration is a structural decision to lower recurring compliance costs and management time. For a small-cap, reduced regulatory overhead can materially improve free cash flow and operational focus, boosting durability if transparency and investor access are managed.
Bears Say
Persistent Operating LossesOngoing negative margins indicate the core business still fails to cover operating costs. Sustained losses erode capital, constrain reinvestment in product and sales, and increase reliance on external financing, which is a durable headwind to recovery over months.
TTM Balance-sheet Red FlagsA TTM snapshot showing zero equity and negative total assets removes the usual solvency buffer. That materially raises bankruptcy and creditor risk, limits borrowing capacity, and makes the firm vulnerable to shocks—an enduring structural weakness for the next several months.
Inconsistent And Currently Negative Cash FlowNegative and uneven operating and free cash flow creates persistent liquidity pressure and forces reliance on external financing or equity raises. Repeated cash burn undermines strategic flexibility and could constrain product investment or working capital over the medium term.
Encision News
ECIA FAQ
What was Encision Inc’s price range in the past 12 months?
Encision Inc lowest stock price was $0.09 and its highest was $0.48 in the past 12 months.
What is Encision Inc’s market cap?
Encision Inc’s market cap is $2.19M.
When is Encision Inc’s upcoming earnings report date?
Encision Inc’s upcoming earnings report date is May 14, 2026 which is in 48 days.
How were Encision Inc’s earnings last quarter?
Currently, no data Available
Is Encision Inc overvalued?
According to Wall Street analysts Encision Inc’s price is currently Overvalued.
Does Encision Inc pay dividends?
Encision Inc does not currently pay dividends.
What is Encision Inc’s EPS estimate?
Encision Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Encision Inc have?
Encision Inc has 16,879,644 shares outstanding.
What happened to Encision Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Encision Inc?
Currently, no hedge funds are holding shares in ECIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.
Technical Analysis
Ownership Overview
52.51% Insiders
6.29% Other Institutional Investors
41.20% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---